Cargando…
Current Strategies in Treating Cytokine Release Syndrome Triggered by Coronavirus SARS-CoV-2
Since the beginning of the SARS-CoV-2 pandemic, the treatments and management of the deadly COVID-19 disease have made great progress. The strategies for developing novel treatments against COVID-19 include antiviral small molecule drugs, cell and gene therapies, immunomodulators, neutralizing antib...
Autores principales: | Wang, Long G, Wang, Luxi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124488/ https://www.ncbi.nlm.nih.gov/pubmed/35611161 http://dx.doi.org/10.2147/ITT.S360151 |
Ejemplares similares
-
Innate Immunity Evasion Strategies of Highly Pathogenic Coronaviruses: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Li, Jin-Yan, et al.
Publicado: (2021) -
Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
por: Dong, Yetian, et al.
Publicado: (2020) -
GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro
por: Hong, Kyung Soo, et al.
Publicado: (2020) -
Coronavirus-Associated Coagulopathy: Lessons From SARS-CoV1 and MERS-CoV for the Current SARS-CoV2 Pandemic
por: Singh, Shalinder, et al.
Publicado: (2020) -
SARS-Coronavirus (SARS-CoV)
por: Kehm, Roland
Publicado: (2009)